Topical administration of Nepafenac inhibits the early stages of diabetic retinopathy

被引：0
|
作者：
Kern, TS
Miller, C
Du, YP
Zheng, L
Mohr, S
Ball, S
Bingaman, DP
机构：
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4703
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TOPICAL ADMINISTRATION OF SOMATOSTATIN AND BRIMONIDINE IN THE EARLY STAGES OF DIABETIC RETINOPATHY: RESULTS OF THE EUROCONDOR STUDY
    Simo, Rafael
    Bandello, Francesco
    Egan, Catherine A.
    Garcia-Arumi, Jose
    Gibson, Jonathan
    Grauslund, Jakob
    Harding, Simon P.
    Lang, Gabriele Elisabeth
    Massin, Pascale
    Midena, Edoardo
    Scanlon, Peter
    Ponsati, Berta
    Porta, Massimo
    Ribeiro, Luisa
    Hernandez, Cristina
    Cunha-Vaz, Jose G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [2] TOPICAL ADMINISTRATION OF SOMATOSTATIN AND BRIMONIDINE IN THE EARLY STAGES OF DIABETIC RETINOPATHY: RESULTS OF THE EUROCONDOR STUDY
    Simo, R.
    Bandello, F.
    Grauslund, J.
    Harding, S. P.
    Ponsati, B.
    Porta, M.
    Cunha-Vaz, J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (03) : E115 - E115
  • [3] Topical administration of somatostatin and brimonidine in the early stages of diabetic retinopathy: results of the EUROCONDOR study
    Simo, R.
    Bandello, F.
    Egan, C.
    Garcia-Arumi, J.
    Gibson, J.
    Grauslund, J.
    Harding, S. P.
    Lang, G. E.
    Massin, P.
    Midena, E.
    Scanlon, P.
    Ponsati, B.
    Porta, M.
    Hernandez, C.
    Cunha-Vaz, J.
    DIABETOLOGIA, 2017, 60 : S55 - S56
  • [4] Inhibition of PARP inhibits development of early stages of diabetic retinopathy
    Kern, TS
    Zheng, L
    Szabo, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [5] Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy
    Zhang, Jin-Zhong
    Xi, Xia
    Gao, Ling
    Kern, Timothy S.
    CURRENT EYE RESEARCH, 2007, 32 (10) : 883 - 889
  • [6] Inhibition of PARP inhibits development of early stages of diabetic retinopathy
    Kern, TS
    Zheng, L
    Szabo, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U404 - U404
  • [7] Topical Nepafenac inhibits ocular neovascularization
    Takahashi, K
    Saishin, Y
    Saishin, Y
    Mori, K
    Ando, A
    Yamamoto, S
    Oshima, Y
    Nambu, H
    Bingamen, D
    Campochiaro, PA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U289 - U289
  • [8] Topical nepafenac inhibits ocular neovascularization
    Takahashi, K
    Saishin, Y
    Saishin, Y
    Mori, K
    Ando, A
    Yamamoto, S
    Oshima, Y
    Nambu, H
    Melia, MB
    Bingaman, DP
    Campochiaro, PA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (01) : 409 - 415
  • [9] Inhibition of P38 Mapk Inhibits Early Stages of Diabetic Retinopathy
    Kern, T. S.
    Du, Y.
    Tang, J.
    Li, G.
    Lee, C. A.
    Bartkowski, D.
    Gale, D.
    Monahan, J. B.
    Niesman, M.
    Alton, G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [10] A marker of early stages of diabetic retinopathy
    Gavrilova, NA
    Lanevskaya, NI
    Antsiferova, NG
    BIOLOGY BULLETIN, 2002, 29 (06) : 577 - 580
12345